Androgenetic alopecia (AGA) – most commonly referred to as male pattern hair loss – is the most frequent form of hair loss in adult men. It is characterized by progressive miniaturization of hair follicles under the influence of androgens, particularly dihydrotestosterone (DHT), and by a characteristic pattern of thinning that typically begins at the frontal hairline and vertex of the scalp. Clinical severity is most commonly graded using the Hamilton–Norwood scale, which ranges from stage I (least severe) to stage VII (most severe) and serves as a standard tool in research and clinical practice for categorizing male pattern hair loss progression.
When AGA begins unusually early in life, before the age typically observed in the broader male population, it is referred to as early-onset AGA. Early-onset AGA is not merely an aesthetic concern; a growing body of evidence links it to clustering of systemic metabolic abnormalities and increased risk for chronic conditions such as metabolic syndrome, insulin resistance, and cardiovascular disease. Because of these associations and shared endocrinologic features with other endocrine–metabolic disorders (notably polycystic ovary syndrome in women), early-onset AGA has become a focus of translational research and epidemiologic investigation.
Defining Early-Onset AGA: One of the foundational challenges in the epidemiologic study of early-onset AGA has been the lack of a single, universally accepted definition across the literature. The 2024 scoping review by Liu and colleagues (see bibliography below), synthesizes definitions used across 65 eligible studies and highlights this heterogeneity.
The review found that:
- Approximately 43% of studies defined early-onset AGA as onset before age 30.
- ~35% of studies used thresholds before 35 or 36 years of age.
- A smaller number of studies extended the definition to onset before 40 years.
- The most frequent method to assess severity was the Hamilton–Norwood scale (used in ~69.2% of male-focused studies).
Thus, while there is no universally mandated cutoff, the conceptual criteria used in the literature defines Early-Onset Androgenetic Alopecia (common operational definition) as:
- AGA clinically evident before the age of 35 (most studies use <30–<36).
- Hair loss severity at least Hamilton–Norwood stage III or higher, indicating clear recession of the frontal hairline and/or vertex thinning.
- Onset of pattern hair loss that represents a deviation from the common age distribution of AGA in the general male population (where a slower age-associated increase is the norm).
Notably, in primary epidemiologic and interventional studies (including those examining metabolic comorbidities), a threshold of before 35 years and Hamilton–Norwood stage ≥III is frequently operationalized as a cut-off for defining “early-onset” in men. This usage reflects both clinical severity and age at initial presentation, aligning phenotypic classification with risk stratification for associated systemic disorders.
Epidemiology and Prevalence: AGA overall affects a majority of men over the lifespan. Estimates suggest that roughly 30–50% of men will exhibit some degree of AGA by age 50, and up to 70% by age 70. However, the prevalence of early-onset AGA in younger populations varies widely due to differences in definition and study design.
Across populations, the scoping review from Liu and colleagues found that the prevalence of early-onset AGA ranges from ~19% to 57% in different cohorts when using age thresholds from <30 to <40. These estimates emphasize the fact that early presentation is not rare and may reflect interactions of genetic susceptibility, androgen sensitivity, and modifiable lifestyle factors.
Pathophysiology: Androgens, Genetics, and Lifestyle: AGA is fundamentally an androgen-mediated disorder. Hair follicle miniaturization in AGA occurs due to the actions of DHT binding to androgen receptors in genetically susceptible follicles. The enzyme 5α-reductase converts testosterone to DHT in dermal papilla cells, which then leads to follicular shrinkage and shortened hair growth cycles.
Early-onset AGA is influenced by a combination of genetic, hormonal, and lifestyle factors:
- Genetic predisposition: Variants in androgen receptor genes and susceptibility loci (e.g., CYP19A1, FSHB, PPARGC1A, and others) have been implicated in AGA risk. These genetic factors may predicate early thinning due to heightened follicular androgen sensitivity.
- Hormonal milieu: Some studies in early-onset cohorts report altered serum hormone profiles, including elevated androgens (testosterone, DHEAS), an increased LH/FSH ratio, higher free androgen index, and reduced sex hormone-binding globulin (SHBG). However, hormonal findings are not uniform across all studies, and additional research is warranted to clarify endocrine patterning.
- Lifestyle influences: Cigarette smoking, unhealthy dietary habits, and higher body mass index (BMI) have emerged as recurrent risk factors in multiple studies.
This multifactorial context aligns with our current understanding that early-onset AGA represents more than an isolated dermatologic phenomenon; it reflects interactions between inherited susceptibility and systemic modulators.
Clinical and Systemic Associations: Early-onset AGA has been progressively linked to broader health concerns beyond the scalp:
- Metabolic Syndrome: Several case–control and cross-sectional studies report that men with early-onset AGA have a significantly higher prevalence of metabolic syndrome (MetS) compared with matched controls. MetS clusters obesity, dyslipidemia, hypertension, and insulin resistance—factors that independently elevate cardiovascular risk. In one meta-analytical subset, early-onset AGA was associated with a ~3.5–3.8-fold increased odds of metabolic syndrome.
- Insulin Resistance and Cardiovascular Risk: Markers of insulin resistance, such as elevated fasting glucose and higher homeostatic model assessment (HOMA) indices, have been observed in men with early-onset AGA. Several studies also document greater carotid intima-media thickness and other surrogate measures of subclinical atherosclerosis in this group, suggesting an upward shift in cardiovascular risk even in younger adults.
- Psychological and Quality-of-Life Impacts: Early-onset AGA can have measurable psychosocial effects, including reduced self-esteem and increased anxiety. These impacts stem from the sociocultural importance of hair and its influence on perceived age and attractiveness, particularly in younger adults confronting premature thinning.
- Other Associations: Emerging evidence – though less consistent – has linked early-onset AGA to prostatic disease and neurological conditions, but these associations require further validation in longitudinal cohorts before conclusions can be drawn.
Clinical Assessment: Diagnosis of AGA generally relies on clinical history and physical examination, with staging using the Hamilton–Norwood scale. In young men presenting with early-onset pattern hair loss, clinicians should:
- Document age of onset, ensuring it aligns with operational thresholds used in research (e.g., <35 years).
- Assess pattern and severity using standardized scales (Hamilton–Norwood).
- Evaluate metabolic risk factors, including blood pressure, lipid profile, fasting glucose, and BMI, due to associations with systemic diseases.
- Consider family history, which is frequently reported in early-onset cases.
Conclusions: Early-onset androgenetic alopecia is a clinically recognizable subgroup of male pattern hair loss with onset in young adulthood, frequently defined in research as occurring before the age of 35 and assessed by established scales such as the Hamilton–Norwood scale. While definitions vary across studies, the combination of age at onset and severity of hair loss forms the basis of most operational criteria.
Beyond hair loss itself, early-onset AGA is linked to metabolic and cardiovascular risk factors, suggesting that it may serve as a phenotypic marker of underlying endocrine–metabolic dysregulation. Multifactorial in origin with contributions from genetics, hormones, and lifestyle factors, early-onset AGA warrants both dermatologic and systemic assessment in young men. Integrating scalp evaluation with broader health screening may enable earlier identification of at-risk individuals and facilitate comprehensive care that addresses both aesthetic and health outcomes.
Bibliography
11711645 {11711645:YE3L7IJJ},{11711645:HNBG5B9P},{11711645:RQMVFQ8V},{11711645:GW35YL22},{11711645:5434YB6M},{11711645:JYU5TUD2},{11711645:PGYCP3XS},{11711645:62EB8XVB} 1 vancouver 50 date asc 2039 https://www.keratin.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%2262EB8XVB%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Matilainen%20et%20al.%22%2C%22parsedDate%22%3A%222001-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BMatilainen%20VA%2C%20M%26%23xE4%3Bkinen%20PK%2C%20Kein%26%23xE4%3Bnen-Kiukaanniemi%20SM.%20Early%20onset%20of%20androgenetic%20alopecia%20associated%20with%20early%20severe%20coronary%20heart%20disease%3A%20a%20population-based%2C%20case-control%20study.%20J%20Cardiovasc%20Risk.%202001%20June%3B8%283%29%3A147%26%23x2013%3B51.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Early%20onset%20of%20androgenetic%20alopecia%20associated%20with%20early%20severe%20coronary%20heart%20disease%3A%20a%20population-based%2C%20case-control%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%20A.%22%2C%22lastName%22%3A%22Matilainen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20K.%22%2C%22lastName%22%3A%22M%5Cu00e4kinen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20M.%22%2C%22lastName%22%3A%22Kein%5Cu00e4nen-Kiukaanniemi%22%7D%5D%2C%22abstractNote%22%3A%22CONTEXT%3A%20The%20relationship%20of%20ischaemic%20heart%20disease%20%28IHD%29%20with%20androgenic%20alopecia%20%28AGA%29%20has%20been%20demonstrated%2C%20but%20no%20differentiation%20between%20early%20and%20late%20onsets%20of%20alopecia%20with%20regard%20to%20the%20risk%20and%20severity%20of%20IHD%20has%20been%20made.%5CnOBJECTIVE%3A%20To%20test%20if%20the%20early%20onset%20of%20alopecia%20is%20a%20risk%20factor%20for%20early%20severe%2C%20coronary%20artery%20disease%20%28CAD%29%20requiring%20surgery%20and%20to%20test%20if%20the%20early%20onset%20of%20AGA%20differs%20in%20this%20respect%20from%20the%20late%20onset%20of%20AGA.%5CnDESIGN%3A%20Population-based%20case-control%20study.%5CnSETTING%20AND%20PARTICIPANTS%3A%20All%20the%2085%20male%20persons%20living%20on%2031%20December%201999%20in%20a%20Finnish%20town%20with%20total%20population%20of%207200%2C%20who%20had%20had%20a%20coronary%20revascularization%20procedure%20between%20March%201987%20and%20January%201999%2C%20were%20drawn%20from%20the%20discharge%20register.%20For%20each%20case%2C%20an%20individually%20selected%20age-matched%20control%20person%20living%20in%20the%20same%20town%20was%20drawn%20from%20the%20official%20census%20register.%5CnMAIN%20OUTCOME%20MEASURE%3A%20Alopecia%20defined%20as%20grade%203%20vertex%20or%20more%20on%20the%20alopecia%20classification%20scale%20of%20Hamilton%2C%20modified%20by%20Norwood%20South%20Med%20J%2C%2068%3A1359-1365%2C%201975.%5CnRESULTS%3A%20The%20unadjusted%20odds%20ratio%20%28OR%29%20for%20coronary%20revascularization%20under%20the%20age%20of%2060%20years%20was%203.57%20%2895%25%20confidence%20interval%20%28CI%29%201.19-10.72%29%20in%20men%20with%20an%20early%20onset%20of%20AGA%20compared%20with%20men%20with%20normal%20hair%20status%20or%20late%20AGA.%20After%20multivariate%20adjustment%20for%20the%20traditional%20CAD%20risk%20factors%2C%20the%20corresponding%20OR%20was%203.18%20%2895%25%20CI%2C%201.01-10.03%29.%20The%20unadjusted%20OR%20for%20the%20coronary%20revascularization%20procedure%20at%20any%20age%20was%202.14%20%2895%25%20CI%2C%201.08-4.23%29%20in%20the%20subgroup%20of%20the%20men%20with%20early%20AGA%20compared%20to%20those%20with%20late%20AGA%20or%20normal%20hair%20status.%20After%20adjustment%20for%20traditional%20risk%20factors%20this%20OR%20was%201.84%2C%20being%20nearly%20significant%20%2895%25%20CI%2C%200.90-3.77%29.%5CnCONCLUSION%3A%20Our%20results%20support%20the%20hypothesis%20that%20the%20early%20onset%20of%20AGA%20is%20a%20risk%20factor%20for%20an%20early%20onset%20of%20severe%20coronary%20heart%20disease.%22%2C%22date%22%3A%222001-06%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1177%5C%2F174182670100800305%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221350-6277%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%226IBCDZH5%22%5D%2C%22dateModified%22%3A%222026-01-02T17%3A28%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22RQMVFQ8V%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cannarella%20et%20al.%22%2C%22parsedDate%22%3A%222018-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BCannarella%20R%2C%20Condorelli%20RA%2C%20Mongio%26%23xEC%3B%20LM%2C%20La%20Vignera%20S%2C%20Calogero%20AE.%20Does%20a%20male%20polycystic%20ovarian%20syndrome%20equivalent%20exist%3F%20J%20Endocrinol%20Invest.%202018%20Jan%3B41%281%29%3A49%26%23x2013%3B57.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Does%20a%20male%20polycystic%20ovarian%20syndrome%20equivalent%20exist%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Cannarella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20A.%22%2C%22lastName%22%3A%22Condorelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20M.%22%2C%22lastName%22%3A%22Mongio%5Cu00ec%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22La%20Vignera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20E.%22%2C%22lastName%22%3A%22Calogero%22%7D%5D%2C%22abstractNote%22%3A%22The%20occurrence%20of%20a%20genetic%20background%20in%20the%20etiology%20of%20polycystic%20ovarian%20syndrome%20%28PCOS%29%20represents%20the%20rational%20basis%20to%20postulate%20the%20existence%20of%20a%20male%20PCOS%20equivalent.%20Hormonal%20and%20metabolic%20abnormalities%20have%20been%20described%20in%20male%20relatives%20of%20women%20with%20PCOS.%20These%20males%20also%20have%20a%20higher%20prevalence%20of%20early%20onset%20%28%26lt%3B35%5Cu00a0years%29%20androgenetic%20alopecia%20%28AGA%29.%20Hence%2C%20this%20feature%20has%20been%20proposed%20as%20a%20clinical%20sign%20of%20the%20male%20PCOS%20equivalent.%20Clinical%20evidence%20has%20shown%20that%20men%20with%20early%20onset%20AGA%20have%20hormonal%20and%20metabolic%20abnormalities.%20Large%20cohort%20studies%20have%20clearly%20shown%20a%20higher%20prevalence%20of%20type%20II%20diabetes%20mellitus%20%28DM%20II%29%20and%20cardiovascular%20diseases%20%28CVDs%29%20in%20elderly%20men%20with%20early%20onset%20AGA.%20In%20addition%2C%20prostate%20cancer%2C%20benign%20prostate%20hyperplasia%20%28BPH%29%20and%20prostatitis%20have%20been%20described.%20These%20findings%20support%20the%20existence%20of%20the%20male%20PCOS%20equivalent%2C%20which%20may%20represent%20an%20endocrine%20syndrome%20with%20a%20metabolic%20background%2C%20and%20might%20predispose%20to%20the%20development%20of%20DM%20II%2C%20CVDs%2C%20prostate%20cancer%2C%20BPH%20and%20prostatitis%20later%20in%20life.%20Its%20acknowledgment%20would%20be%20helpful%20for%20the%20prevention%20of%20these%20long-term%20complications.%22%2C%22date%22%3A%222018-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1007%5C%2Fs40618-017-0728-5%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221720-8386%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%226IBCDZH5%22%5D%2C%22dateModified%22%3A%222026-01-02T17%3A31%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22HNBG5B9P%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cannarella%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BCannarella%20R%2C%20Condorelli%20RA%2C%20Dall%26%23x2019%3BOglio%20F%2C%20La%20Vignera%20S%2C%20Mongio%26%23xEC%3B%20LM%2C%20Micali%20G%2C%20et%20al.%20Increased%20DHEAS%20and%20Decreased%20Total%20Testosterone%20Serum%20Levels%20in%20a%20Subset%20of%20Men%20with%20Early-Onset%20Androgenetic%20Alopecia%3A%20Does%20a%20Male%20PCOS-Equivalent%20Exist%3F%20Int%20J%20Endocrinol.%202020%3B2020%3A1942126.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Increased%20DHEAS%20and%20Decreased%20Total%20Testosterone%20Serum%20Levels%20in%20a%20Subset%20of%20Men%20with%20Early-Onset%20Androgenetic%20Alopecia%3A%20Does%20a%20Male%20PCOS-Equivalent%20Exist%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rossella%22%2C%22lastName%22%3A%22Cannarella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosita%20A.%22%2C%22lastName%22%3A%22Condorelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Federica%22%2C%22lastName%22%3A%22Dall%27Oglio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandro%22%2C%22lastName%22%3A%22La%20Vignera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20M.%22%2C%22lastName%22%3A%22Mongio%5Cu00ec%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giuseppe%22%2C%22lastName%22%3A%22Micali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aldo%20E.%22%2C%22lastName%22%3A%22Calogero%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Increased%20dehydroepiandrosterone%20sulfate%20%28DHEAS%29%20levels%20have%20been%20reported%20in%20men%20with%20early-onset%20%28%26lt%3B35%20years%29%20androgenetic%20alopecia%20%28AGA%29.%20It%20has%20been%20suggested%20that%20a%20male%20polycystic%20ovarian%20syndrome-%20%28PCOS-%29%20equivalent%2C%20defined%20as%20an%20endocrine%20syndrome%20with%20a%20metabolic%20background%20and%20a%20PCOS-like%20hormonal%20pattern%2C%20predisposing%20to%20type%20II%20diabetes%20mellitus%20%28DM%20II%29%2C%20cardiovascular%20and%20prostate%20diseases%20later%20in%20life%2C%20may%20occur%20in%20at%20least%20a%20part%20of%20these%20men.%20The%20gonadal%20function%2C%20including%20sperm%20parameters%20and%20total%20testosterone%20%28TT%29%20levels%2C%20has%20been%20investigated%20in%20a%20low%20number%20of%20these%20men.%5CnOBJECTIVE%3A%20The%20aim%20of%20the%20study%20was%20to%20assess%20gonadal%20and%20adrenal%20function%20in%20a%20subset%20of%20men%20with%20early-onset%20AGA%20and%20controls.%5CnMETHODS%3A%2043%20men%20with%20early-onset%20AGA%20and%2036%20controls%20were%20screened%20for%20DHEAS%2C%20TT%2C%20glycaemia%2C%20insulin%2C%20gonadotropins%2C%2017%5Cu03b1-hydroxyprogesterone%20%2817%5Cu03b1-hydroxyprogesterone%20%2817n%5Cu2009%3D%5Cu200921%29%2C%20as%20those%20with%20at%20least%20one%20of%20the%20following%20parameters%3A%20body%20mass%20index%20%28BMI%29%20%26gt%3B25%5Cu2009kg%5C%2Fm2%2C%20insulin%20resistance%20%28IR%29%2C%20and%5C%2For%20SHBG%20%26lt%3B25%5Cu2009nmol%5C%2Fl.%5CnRESULTS%3A%20Patients%20with%20early-onset%20AGA%20had%20higher%20mean%20%28%5Cu00b1SD%29%20BMI%20%2825.5%5Cu2009%5Cu00b1%5Cu20093.8%20vs.%2023.7%5Cu2009%5Cu00b1%5Cu20093.0%5Cu2009kg%5C%2Fm2%3B%20P%20%26lt%3B%200.05%29%20and%2017%5Cu03b1-hydroxyprogesterone%20%2817P%20%26lt%3B%200.05%29%20and%2017P%20%26lt%3B%200.05%29%20and%2017P%20%26lt%3B%200.05%29%20and%2017P%20%26lt%3B%200.05%29%20and%2017%5Cu03bcg%5C%2Fdl%3B%20P%20%26lt%3B%200.05%29%20and%2017P%20%26lt%3B%200.05%29%20and%2017P%20%26lt%3B%200.05%29%20and%2017P%20%26lt%3B%200.05%29%20and%2017.%5CnCONCLUSION%3A%20Men%20with%20early-onset%20AGA%20and%20at%20least%20one%20among%20BMI%20%26gt%3B25%5Cu2009kg%5C%2Fm2%2C%20IR%2C%20and%20SHBG%20%26lt%3B25%5Cu2009nmol%5C%2Fl%20have%20increased%20DHEAS%20levels%20and%20a%20worse%20gonadal%20steroidogenesis.%20They%20might%20have%20a%20greater%20risk%20to%20develop%20gonadal%20dysfunction%20later%20in%20life.%20These%20criteria%20may%20be%20used%20to%20define%20male%20PCOS-equivalent.%22%2C%22date%22%3A%222020%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1155%5C%2F2020%5C%2F1942126%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221687-8337%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%226IBCDZH5%22%5D%2C%22dateModified%22%3A%222026-01-02T17%3A31%3A22Z%22%7D%7D%2C%7B%22key%22%3A%225434YB6M%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Vinay%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BVinay%20K%2C%20Bhattachajee%20R%2C%20Bishnoi%20A%2C%20Kaushik%20A%2C%20Sachdeva%20N%2C%20Pal%20A%2C%20et%20al.%20Clinical%20and%20metabolic%20characteristics%20of%20males%20with%20early-onset%20androgenetic%20alopecia.%20Indian%20J%20Dermatol%20Venereol%20Leprol.%202023%3B89%284%29%3A530%26%23x2013%3B5.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20and%20metabolic%20characteristics%20of%20males%20with%20early-onset%20androgenetic%20alopecia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keshavamurthy%22%2C%22lastName%22%3A%22Vinay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajsmita%22%2C%22lastName%22%3A%22Bhattachajee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anuradha%22%2C%22lastName%22%3A%22Bishnoi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Akanksha%22%2C%22lastName%22%3A%22Kaushik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naresh%22%2C%22lastName%22%3A%22Sachdeva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnab%22%2C%22lastName%22%3A%22Pal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tarun%22%2C%22lastName%22%3A%22Narang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sunil%22%2C%22lastName%22%3A%22Dogra%22%7D%5D%2C%22abstractNote%22%3A%22Background%20Men%20with%20early-onset%20androgenetic%20alopecia%20%28AGA%29%20often%20have%20an%20abnormal%20hormonal%20milieu.%20Objective%20To%20ascertain%20the%20clinico-phenotypic%20characteristics%20and%20the%20prevalence%20of%20hormonal%20and%20metabolic%20changes%20in%20men%20with%20early-onset%20AGA.%20Methods%20Consecutive%20male%20patients%20less%20than%2030%20years%20of%20age%20with%20a%20Norwood-Hamilton%20grade%20%5Cu22653%20AGA%20were%20recruited%20in%20this%20comparative%20cross-sectional%20study.%20After%20endocrine%20evaluation%20they%20were%20classified%20into%20two%20groups%2C%20that%20is%2C%20Group%20A%20consisting%20of%20subjects%20with%20an%20altered%20hormonal%20profile%20and%20Group%20B%20with%20normal%20hormonal%20profiles.%20The%20groups%20were%20assessed%20for%20differences%20in%20disease%20phenotype%20and%20severity%20%28Norwood-Hamilton%20grade%29%2C%20insulin%20resistance%20and%20parameters%20of%20metabolic%20syndrome%20%28ATP%20III%20guidelines%29.%20Results%20Altered%20hormonal%20profiles%20were%20seen%20in%2034%20of%20the%20100%20subjects%20with%20AGA%2C%20while%20insulin%20resistance%20and%20metabolic%20syndrome%20were%20noted%20in%2044%20and%2026%20respectively.%20Altered%20hormonal%20profiles%20were%20significantly%20associated%20with%20insulin%20resistance%20and%20severe%20alopecia%20%28grade%204%20and%20above%20Hamilton-Norwood%20Scale%29.%20Insulin%20resistant%20Group%20A%20patients%20had%20a%20significantly%20higher%20prevalence%20of%20severe%20alopecia%20%28%26gt%3Bgrade%204%29%20%28P%20%3D%200.0036%29.%20The%20prevalence%20of%20metabolic%20syndrome%20was%20similar%20in%20both%20groups.%20Limitation%20The%20cross%20sectional%20study%20design%20was%20a%20drawback%20of%20this%20study.%20Further%2C%20a%20control%20arm%20without%20AGA%20was%20not%20included%20and%20the%20sample%20size%20of%20100%20was%20selected%20arbitrarily.%20Conclusion%20An%20altered%20hormonal%20profile%20and%20insulin%20resistance%20was%20noted%20in%20a%20third%20of%20the%20males%20with%20early-onset%20AGA.%20Subjects%20with%20altered%20hormonal%20profiles%20had%20a%20higher%20prevalence%20of%20insulin%20resistance%20and%20were%20likely%20to%20have%20severe%20grades%20of%20AGA.%22%2C%22date%22%3A%222023%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.25259%5C%2FIJDVL_949_2021%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220973-3922%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%226IBCDZH5%22%5D%2C%22dateModified%22%3A%222026-01-02T17%3A30%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22JYU5TUD2%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Liu%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BLiu%20LP%2C%20Wariboko%20MA%2C%20Hu%20X%2C%20Wang%20ZH%2C%20Wu%20Q%2C%20Li%20YM.%20Factors%20associated%20with%20early-onset%20androgenetic%20alopecia%3A%20A%20scoping%20review.%20PLoS%20One.%202024%3B19%283%29%3Ae0299212.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Factors%20associated%20with%20early-onset%20androgenetic%20alopecia%3A%20A%20scoping%20review%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Li-Ping%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%20Adumo%22%2C%22lastName%22%3A%22Wariboko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiao%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zi-Han%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qian%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-Mei%22%2C%22lastName%22%3A%22Li%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Early-onset%20androgenetic%20alopecia%20%28AGA%29%20has%20been%20associated%20with%20various%20chronic%20conditions%2C%20including%20metabolic%20syndrome%20%28MetS%29.%20Gaining%20a%20deep%20understanding%20of%20early-onset%20AGA%20may%20enable%20earlier%20intervention%20in%20individuals%20at%20high%20risks.%20This%20scoping%20review%20aims%20to%20explore%20the%20risk%20factors%20and%20etiology%2C%20associated%20conditions%2C%20and%20adverse%20effects%20on%20wellbeing%20in%20early-onset%20AGA.%5CnMETHODS%3A%20Electronic%20literature%20searches%20were%20conducted%20in%20MEDLINE%2C%20EMBASE%20and%20CENTRIAL.%20Eligible%20studies%20included%20case-control%2C%20cohort%2C%20cross-sectional%2C%20and%20meta-analysis%20studies.%20Selected%20studies%20needed%20to%20clearly%20define%20early-onset%20AGA%20cases%20or%20include%20only%20cases%20starting%20before%20the%20age%20of%2040%20and%20compare%20them%20with%20appropriate%20controls.%20The%20exclusion%20criteria%20comprised%20editorials%2C%20commentaries%2C%20case%20series%2C%20and%20non-systematic%20reviews%2C%20among%20others.%20Data%20extraction%20involved%20collecting%20study%20characteristics%2C%20methodologies%2C%20main%20outcomes%2C%20and%20findings.%20Descriptive%20tables%20were%20used%20to%20summarize%20key%20information%20and%20relevant%20variables%20when%20necessary.%5CnRESULTS%3A%20Among%20the%2065%20eligible%20articles%2C%2067.69%25%20were%20case-control%20studies%20and%2078.46%25%20evaluated%20only%20male%20patients.%20%26quot%3BEarly-onset%26quot%3B%20was%20defined%20as%20cases%20developing%20before%20the%20age%20of%2030%20years%20in%2043.08%25%20of%20the%20studies.%20The%20Hamilton-Norwood%20scale%20was%20the%20most%20frequently%20used%20method%20for%20evaluating%20the%20severity%20of%20alopecia%20in%20men%20%2869.23%25%29.%20Reported%20risk%20factors%20for%20early-onset%20AGA%20included%20a%20family%20history%20of%20AGA%2C%20cigarette%20smoking%2C%20unhealthy%20dietary%20habits%2C%20and%20a%20high%20body%20mass%20index.%20Early-onset%20AGA%20may%20also%20be%20associated%20with%20hormonal%20profiles%2C%205%5Cu03b1-reductase%20enzyme%20activity%2C%20androgen%20receptor%20genes%2C%20and%20some%20susceptibility%20loci.%20Comorbidities%20investigated%20included%20MetS%2C%20cardiovascular%20disease%2C%20insulin%20resistance%2C%20dyslipidemia%2C%20and%20Parkinson%26%23039%3Bs%20disease.%20Men%20with%20early-onset%20AGA%20may%20have%20reduced%20treatment%20efficacy%20with%20drug%20like%20rosuvastatin%2C%20metformin%20or%20lisinopril%20for%20dyslipidemia%2C%20prediabetes%2C%20or%20hypertension.%20Additionally%2C%20young%20men%20with%20AGA%20tended%20to%20suffer%20from%20psychological%20issues%20such%20as%20anxiety%20and%20low%20self-esteem%20compared%20to%20those%20without%20hair%20loss.%5CnCONCLUSION%3A%20Early-onset%20AGA%20is%20a%20complex%20condition%20with%20various%20risk%20factors%20and%20etiology%2C%20associated%20comorbidities%2C%20and%20potential%20implications%20for%20treatment%20response%20and%20psychological%20health.%22%2C%22date%22%3A%222024%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0299212%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221932-6203%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%226IBCDZH5%22%5D%2C%22dateModified%22%3A%222026-01-02T17%3A29%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22GW35YL22%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Legiawati%20et%20al.%22%2C%22parsedDate%22%3A%222024-08-29%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BLegiawati%20L%2C%20Sitohang%20IBS%2C%20Yusharyahya%20SN%2C%20Sirait%20SP%2C%20Novianto%20E%2C%20Yunir%20E%2C%20et%20al.%20The%20comparison%20of%20metabolic%20syndrome%20parameters%2C%20trichoscopic%20and%20trichoscan%20characteristics%20in%20androgenetic%20alopecia%20%28AGA%29%20and%20early-onset%20androgenetic%20alopecia%20%28early-onset%20AGA%29.%20Arch%20Dermatol%20Res.%202024%20Aug%2029%3B316%288%29%3A581.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20comparison%20of%20metabolic%20syndrome%20parameters%2C%20trichoscopic%20and%20trichoscan%20characteristics%20in%20androgenetic%20alopecia%20%28AGA%29%20and%20early-onset%20androgenetic%20alopecia%20%28early-onset%20AGA%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lili%22%2C%22lastName%22%3A%22Legiawati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irma%20Bernadette%20S.%22%2C%22lastName%22%3A%22Sitohang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannaz%20Nadia%22%2C%22lastName%22%3A%22Yusharyahya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sondang%20P.%22%2C%22lastName%22%3A%22Sirait%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Endi%22%2C%22lastName%22%3A%22Novianto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Em%22%2C%22lastName%22%3A%22Yunir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brigitta%20Cindy%22%2C%22lastName%22%3A%22Lauren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadhira%20Permata%22%2C%22lastName%22%3A%22Hakiki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faizal%20Dzaky%22%2C%22lastName%22%3A%22Rahmadika%22%7D%5D%2C%22abstractNote%22%3A%22Androgenetic%20alopecia%20%28AGA%29%2C%20the%20most%20common%20cause%20of%20hair%20loss%2C%20is%20influenced%20by%20various%20risk%20factors.%20Metabolic%20syndrome%20constitutes%20a%20collection%20of%20risk%20factors%20elevating%20the%20risk%20of%20cardiovascular%20disease.%20The%20presence%20of%20early-onset%20AGA%20could%20serve%20as%20an%20indicator%20of%20the%20emergence%20of%20metabolic%20syndrome%2C%20yet%20to%20date%2C%20no%20research%20has%20examined%20these%20parameters%20in%20AGA.%20This%20is%20a%20cross-sectional%20study%20comparing%20two%20groups%3B%20early%20onset%20versus%20normal%20onset%20AGA.%20Forty%20participants%20were%20enlisted%20and%20evenly%20distributed%20into%20the%20two%20groups.%20Subsequently%2C%20participants%20underwent%20examinations%20utilizing%20trichoscopy%2C%20trichoscan%2C%20and%20laboratory%20assessments.%20Apart%20from%20waist%20circumference%2C%20BMI%2C%20and%20age%20of%20alopecia%20onset%2C%20there%20were%20no%20notable%20differences%20concerning%20sociodemographic%20and%20clinical%20features.%20In%20terms%20of%20hair%20growth%20parameters%2C%20the%20telogen%20hair%20rate%20stands%20out%20as%20the%20sole%20indicator%20exhibiting%20a%20significant%20difference%20between%20both%20groups%2C%20while%20trichoscopy%20data%20also%20revealed%20varying%20hair%20characteristics.%20Lastly%2C%20metabolic%20parameters%20namely%20triglyceride%2C%20fasting%20blood%20glucose%2C%20HbA1c%20and%20HDL%20differ%20significantly%2C%20with%20the%20normal%20onset%20group%20demonstrating%20a%20higher%20prevalence%20of%20metabolic%20abnormality.%20This%20suggests%20a%20potential%20association%20between%20AGA%20and%20metabolic%20syndrome.%20However%2C%20the%20exact%20nature%20of%20this%20relationship%20remains%20uncertain%2C%20necessitating%20further%20research%20with%20larger%20samples%2C%20specific%20age%20groups%20and%20diverse%20study%20designs.%22%2C%22date%22%3A%222024-08-29%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00403-024-03297-2%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221432-069X%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%226IBCDZH5%22%5D%2C%22dateModified%22%3A%222026-01-02T17%3A30%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22YE3L7IJJ%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Majella%20and%20Aithal%22%2C%22parsedDate%22%3A%222025%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BMajella%20S%2C%20Aithal%20V.%20Is%20Early-onset%20Androgenetic%20Alopecia%20Associated%20with%20Metabolic%20Syndrome%3F%20-%20A%20Descriptive%20Cross-sectional%20Study.%20Int%20J%20Trichology.%202025%3B17%281%29%3A36%26%23x2013%3B41.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Is%20Early-onset%20Androgenetic%20Alopecia%20Associated%20with%20Metabolic%20Syndrome%3F%20-%20A%20Descriptive%20Cross-sectional%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheena%22%2C%22lastName%22%3A%22Majella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijay%22%2C%22lastName%22%3A%22Aithal%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Androgenetic%20alopecia%20%28AGA%29%2C%20although%20considered%20medically%20benign%2C%20has%20been%20found%20to%20be%20associated%20with%20increased%20cardiovascular%20risk%2C%20especially%20in%20patients%20with%20early%20onset%20%28%5Cu2264%2030%20years%29.%20Metabolic%20syndrome%20%28MetS%29%20comprises%20a%20cluster%20of%20cardiovascular%20risk%20factors%20predicting%20morbidity.%20Very%20few%20studies%20focused%20on%20early%20development%20of%20MetS%20in%20younger%20males%20and%20the%20association%20with%20the%20severity%20of%20AGA%2C%20necessitating%20further%20research.%5CnOBJECTIVES%3A%20To%20estimate%20the%20prevalence%20of%20MetS%20in%20men%20with%20early-onset%20AGA%20and%20to%20assess%20if%20there%20is%20a%20positive%20correlation%20between%20the%20severity%20of%20AGA%20and%20the%20development%20of%20MetS%20and%20its%20components.%5CnMATERIALS%20AND%20METHODS%3A%20A%20cross-sectional%20study%20was%20undertaken%20in%20a%20tertiary%20care%20hospital%20from%20November%202020%20to%20October%202022%2C%20on%20men%20in%20the%20age%20group%20of%2018%20-%2040%20years.%20100%20men%20with%20early-onset%20AGA%20%28%5Cu2264%2030%20years%29%20were%20included%20in%20the%20study.%20MetS%20was%20diagnosed%20as%20per%20the%20criteria%20by%20the%20International%20Diabetes%20Federation%20%28IDF%29%2C%20and%20American%20Heart%20Association%5C%2F%20National%20Heart%2C%20Lung%20and%20Blood%20Institute%20%28AHA%5C%2FNHLBI%29.%20Chi-square%20test%20and%20student%26%23039%3Bs%20t-test%20were%20used%20for%20statistical%20analysis.%5CnRESULTS%3A%20Metabolic%20syndrome%20was%20diagnosed%20in%2063%20%2863%25%29%20of%20the%20patients.%20The%20prevalence%20of%20MetS%20%28P%20%3D%200.006%29%2C%20elevated%20waist%20circumference%20%28P%20%3D%200.006%29%2C%20elevated%20serum%20triglycerides%20%28P%20%3D%200.011%29%2C%20and%20mean%20value%20of%20serum%20high-density%20lipoprotein%20%28P%20%3D%200.05%29%20was%20statistically%20significant%20in%20patients%20with%20severe%20AGA.%5CnCONCLUSION%3A%20A%20high%20prevalence%20of%20metabolic%20syndrome%20was%20found%20in%20young%20males%20with%20early-onset%20AGA.%20Screening%20and%20lifestyle%20modifications%20should%20be%20enforced%20earlier%20to%20lessen%20cardiovascular%20morbidity%20and%20mortality%20in%20young%20male%20patients%20with%20AGA.%22%2C%22date%22%3A%222025%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.4103%5C%2Fijt.ijt_135_23%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220974-7753%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%226IBCDZH5%22%5D%2C%22dateModified%22%3A%222026-01-02T17%3A32%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22PGYCP3XS%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Erden%20et%20al.%22%2C%22parsedDate%22%3A%222025-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BErden%20O%2C%20Yorulmaz%20A%2C%20Yalcin%20B.%20Increased%20Prevalence%20of%20Insulin%20Resistance%20and%20Metabolic%20Syndrome%20in%20Men%20With%20Early-Onset%20Androgenetic%20Alopecia%3A%20A%20Case-Control%20Study.%20J%20Cosmet%20Dermatol.%202025%20Dec%3B24%2812%29%3Ae70458.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Increased%20Prevalence%20of%20Insulin%20Resistance%20and%20Metabolic%20Syndrome%20in%20Men%20With%20Early-Onset%20Androgenetic%20Alopecia%3A%20A%20Case-Control%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Orkun%22%2C%22lastName%22%3A%22Erden%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahu%22%2C%22lastName%22%3A%22Yorulmaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Basak%22%2C%22lastName%22%3A%22Yalcin%22%7D%5D%2C%22abstractNote%22%3A%22AIM%3A%20This%20study%20aimed%20to%20investigate%20the%20relationship%20between%20early-onset%20androgenetic%20alopecia%20%28AGA%29%20and%20the%20prevalence%20of%20insulin%20resistance%20%28IR%29%20and%20metabolic%20syndrome%20%28MetS%29%20in%20young%20adult%20males.%5CnMETHODS%3A%20A%20total%20of%20200%20males%20aged%2018%20to%2035%5Cu2009years%20were%20enrolled%20in%20this%20case-control%20study%2C%20including%20100%20patients%20with%20early-onset%20AGA%20and%20100%20age-%20and%20body%20mass%20index-matched%20controls.%20Clinical%20staging%20was%20performed%20using%20the%20Hamilton-Norwood%20classification%2C%20and%20all%20participants%20underwent%20standardized%20physical%20and%20biochemical%20evaluation.%5CnRESULTS%3A%20The%20prevalence%20of%20insulin%20resistance%20%28HOMA-IR%20%5Cu2265%5Cu20092.7%29%20was%20significantly%20higher%20in%20the%20AGA%20group%20compared%20to%20the%20control%20group%20%2818%25%20vs.%204%25%2C%20p%5Cu2009%3D%5Cu20090.003%29.%20Similarly%2C%20MetS%20was%20more%20common%20among%20AGA%20patients%20%2821%25%20vs.%209%25%2C%20p%5Cu2009%3D%5Cu20090.011%29.%20Fasting%20insulin%20levels%2C%20triglyceride%20concentrations%2C%20and%20HOMA-IR%20scores%20were%20all%20significantly%20elevated%20in%20the%20AGA%20group%2C%20while%20HDL-C%20levels%20were%20comparable%20between%20groups.%20Waist%20circumference%20was%20also%20significantly%20greater%20in%20the%20AGA%20group%20%28p%5Cu2009%3D%5Cu20090.026%29.%20When%20stratified%20by%20AGA%20severity%2C%20the%20frequency%20of%20IR%20progressively%20increased%20with%20increasing%20Hamilton-Norwood%20stages.%20No%20significant%20differences%20were%20observed%20in%20fasting%20glucose%20or%20blood%20pressure%20categories.%20Although%20individual%20MetS%20components%20were%20similar%2C%20cumulative%20clustering%20of%20risk%20factors%20appeared%20to%20be%20associated%20with%20a%20significantly%20higher%20MetS%20frequency%20among%20patients%20with%20AGA.%5CnCONCLUSION%3A%20Early-onset%20AGA%20in%20men%20may%20serve%20as%20a%20visible%20clinical%20indicator%20of%20underlying%20metabolic%20disturbances%2C%20particularly%20IR.%20Routine%20metabolic%20screening%20may%20be%20advisable%20in%20young%20men%20presenting%20with%20advanced%20AGA%20stage.%22%2C%22date%22%3A%222025-12%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1111%5C%2Fjocd.70458%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221473-2165%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%226IBCDZH5%22%5D%2C%22dateModified%22%3A%222026-01-02T17%3A29%3A23Z%22%7D%7D%5D%7D
1.
Matilainen VA, Mäkinen PK, Keinänen-Kiukaanniemi SM. Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case-control study. J Cardiovasc Risk. 2001 June;8(3):147–51.
1.
Cannarella R, Condorelli RA, Mongioì LM, La Vignera S, Calogero AE. Does a male polycystic ovarian syndrome equivalent exist? J Endocrinol Invest. 2018 Jan;41(1):49–57.
1.
Cannarella R, Condorelli RA, Dall’Oglio F, La Vignera S, Mongioì LM, Micali G, et al. Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist? Int J Endocrinol. 2020;2020:1942126.
1.
Vinay K, Bhattachajee R, Bishnoi A, Kaushik A, Sachdeva N, Pal A, et al. Clinical and metabolic characteristics of males with early-onset androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2023;89(4):530–5.
1.
Liu LP, Wariboko MA, Hu X, Wang ZH, Wu Q, Li YM. Factors associated with early-onset androgenetic alopecia: A scoping review. PLoS One. 2024;19(3):e0299212.
1.
Legiawati L, Sitohang IBS, Yusharyahya SN, Sirait SP, Novianto E, Yunir E, et al. The comparison of metabolic syndrome parameters, trichoscopic and trichoscan characteristics in androgenetic alopecia (AGA) and early-onset androgenetic alopecia (early-onset AGA). Arch Dermatol Res. 2024 Aug 29;316(8):581.
1.
Majella S, Aithal V. Is Early-onset Androgenetic Alopecia Associated with Metabolic Syndrome? - A Descriptive Cross-sectional Study. Int J Trichology. 2025;17(1):36–41.
1.
Erden O, Yorulmaz A, Yalcin B. Increased Prevalence of Insulin Resistance and Metabolic Syndrome in Men With Early-Onset Androgenetic Alopecia: A Case-Control Study. J Cosmet Dermatol. 2025 Dec;24(12):e70458.
